Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bioptimus logo — We build foundation models that will transform biology.

Bioptimus

We build foundation models that will transform biology.

Founded 2024 France France 44 employees Series A Total: $76.00M Biotechnology, Pharmaceutical

General Information

Company Name Bioptimus
Founded Year 2024
Location France France +1
Founders / Decision Makers
Team member
Employees 44
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when Bioptimus moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Bioptimus is rapidly solidifying its position in AI-driven biology, demonstrating significant product leadership with its M-Optimus-1 model achieving a 60% performance improvement over state-of-the-art. Despite a challenging French tech landscape, the company is actively expanding its team, pursuing strategic data partnerships, and elevating its leadership's profile. This aggressive growth trajectory, supported by substantial funding, positions Bioptimus as a key player focused on R&D excellence and ecosystem building in the competitive foundation models for biology sector.

Signal Types
Product Development Traction Hiring Business Development Media Coverage
Strategic Labels
AI in Biology Product Validation Ecosystem Building
Next Move: Expansion
·
Impact: 8/10
·
Ideal For: AI/Biotech VCs — Growth Stage

About Bioptimus

Bioptimus is a forward-thinking company established in 2024 in France, specializing in the Biotechnology and Pharmaceutical industries. The startup’s mission is encapsulated in its slogan: "We build foundation models that will transform biology."

Bioptimus leverages cutting-edge technology to convert multiscale data into actionable insights, positioning itself as a leader in fostering breakthrough discoveries. As part of its strategy, the company is developing foundation models aimed at revolutionizing biological sciences.

Most recently, Bioptimus secured a substantial $41.00M Series A investment on 01 January 2025. This round of funding was supported by an impressive lineup of investors, including Cathay Innovation, Bpifrance, Sofinnova Investments, Andera Partner, Boom Capital Ventures, Hitachi Ventures, Emmanuel Cassimatis, and Thomas Wolf. Bioptimus's promising technology and strong investor backing signal significant growth potential in the biotech sector.

Taxonomy: foundation models, multiscale data, biological data integration, AI in biology, biological processes, computational biology, biological discoveries, data-driven biology, universal AI, advanced computing power, molecular biology, organismal biology, data representation

Services & Products

Biological Data Generation
Multimodal Foundation Model Development
Drug Response Prediction
Biomarker and Target Discovery
Spatial Transcriptomics Integration

Target Customers

Pharmaceutical Companies Biotech Researchers Clinical Trial Organizations Academic Institutions Healthcare Providers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Jan 2025
Seed •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Feb 2024

Latest News

View All
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model — Venturebeat.com
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model
Venturebeat.com Feb 20, 2024
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI... — Businesswire.com
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
Businesswire.com Feb 20, 2024
La startup Bioptimus, mêlant biologie et IA, se lance après avoir levé 35 millions de dollars — Maddyness.com
La startup Bioptimus, mêlant biologie et IA, se lance après avoir levé 35 millions de dollars
Maddyness.com Feb 20, 2024
Bioptimus, la start-up française qui veut devenir le ChatGPT de la biologie — Lesechos.fr
Bioptimus, la start-up française qui veut devenir le ChatGPT de la biologie
Lesechos.fr Feb 20, 2024
D’anciens chercheurs de Google DeepMind et des experts d'Owkin unissent leurs talents pour inaugurer... — Presse.bpifrance.fr
D’anciens chercheurs de Google DeepMind et des experts d'Owkin unissent leurs talents pour inaugurer Bioptimus, un modèle d'IA révolutionnaire dédié à la biologie
Presse.bpifrance.fr Feb 20, 2024
Lancée par des anciens de Google et Owkin, la start-up Bioptimus lève 32 millions d'euros — Usine-digitale.fr
Lancée par des anciens de Google et Owkin, la start-up Bioptimus lève 32 millions d'euros
Usine-digitale.fr Feb 21, 2024

Bioptimus Alternatives & Competitors

View All Alternatives
Bioptimus vs
Synteny
Synteny United Kingdom

Decoding biology to end disease.

Series A
20 employees
Compare Bioptimus vs Synteny
Bioptimus vs
Latent Labs
Latent Labs

Frontier models for all molecules of life.

Series A
22 employees
Biotechnology
Compare Bioptimus vs Latent Labs
Bioptimus vs
CardiaTec Bio
CardiaTec Bio United Kingdom

Decoding cardiovascular disease biology for novel therapeutic discovery

Pre Seed
17 employees
AI, Biotechnology
Compare Bioptimus vs CardiaTec Bio
View all alternatives

FAQ About Bioptimus

We build foundation models that will transform biology.
Bioptimus was founded in 2024.
Bioptimus is headquartered in France.
Bioptimus operates in the following industries: Biotechnology, Pharmaceutical.
Bioptimus has approximately 44 employees.
Bioptimus has completed 2 funding rounds, raising a total of $76.00M. The latest funding stage is Series A.
Bioptimus offers: Biological Data Generation, Multimodal Foundation Model Development, Drug Response Prediction, Biomarker and Target Discovery, Spatial Transcriptomics Integration.
Top alternatives and competitors to Bioptimus include Synteny, Latent Labs, CardiaTec Bio, Origin, BforCure. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioptimus and Synteny are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Bioptimus and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy